YOLFTbeta
Wiltrom Co., Ltd.

Wiltrom Co., Ltd.

6767 · TWO · Healthcare / Medical Devices

23.00TWD-0.85 (-3.56%)

Price History

Full chart

Market Stats

Previous Close23.85
Open23.40
Day Range23.00 – 23.40
52-Week Range22.25 – 30.70
Volume5.33K
Market Cap958.04M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.44
Dividend Yield0.00%
Beta0.49
50-Day Avg24.77
200-Day Avg26.79

About

Wiltrom Co., Ltd. researches, develops, manufactures, and sells medical equipment in Taiwan. It offers spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. The company was founded in 1998 and is based in Zhubei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Huang-Qian Liang
  • Employees51
  • HeadquartersNo.26, Shengyi Road, Zhubei, Taiwan, 302, Taiwan
  • Websitehttps://www.wiltrom.com.tw

Leadership

  • Mr. Huang-Qian LiangChairman & GM
  • Mr. Yi-Chun SuCOO & Director
  • De Yang CaiChief of Legal

Financials

Income Statement

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue144.50M206.86M282.54M334.73M311.77M
Growth (%)-+43.16%+36.58%+18.47%-6.86%
Cost of Revenue42.11M50.26M59.94M70.96M68.55M
Gross Profit102.39M156.61M222.60M263.77M243.22M
Gross Margin70.86%75.71%78.79%78.80%78.01%
Operating Expense137.29M166.40M241.00M312.13M271.61M
Operating Income-34.90M-9.79M-18.40M-48.36M-28.39M
Operating Margin-24.15%-4.73%-6.51%-14.45%-9.11%
EBITDA-1.67M22.23M-25.25M3.63M
EBITDA Margin-0.81%7.87%-7.54%1.16%
Net Income-47.39M-16.98M1.49M-49.05M-19.10M
Net Income Margin-32.80%-8.21%0.53%-14.65%-6.13%
R&D35.08M39.36M49.13M80.24M55.79M
R&D as % of Total Revenue24.27%19.03%17.39%23.97%17.90%
Interest Expense376.00K1.11M1.53M1.62M1.64M
Interest Expense % of Total Revenue0.26%0.54%0.54%0.49%0.53%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets502.48M504.01M497.50M732.38M710.68M
Total Liabilities116.47M134.66M126.69M140.41M137.96M
Total Equity386.01M369.35M370.81M591.96M572.72M
Cash124.53M68.87M44.09M101.93M91.84M
Net Debt-14.52M33.00M--

Cash Flow

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-19.96M-5.48M-15.46M-26.98M-4.68M
Capital Expenditure24.85M54.80M38.21M15.18M10.01M
Free Cash Flow-44.81M-60.27M-53.66M-42.16M-14.69M
FCF to OCF224.45%1100.51%347.18%156.27%314.02%

Earnings

Report DateDec 31, 2020May 5, 2021Aug 4, 2021May 5, 2022Aug 4, 2022Nov 3, 2022
EPS Estimate0.030.350.42---
EPS Actual-0.58-0.77-0.53-0.33-0.160.08
Surprise-2033.33%-320.00%-226.19%---
Timing-After-hoursAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap958.04M
Enterprise Value709.30M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.05
Price / Book1.67
EPS-0.44
Book Value14.60
Revenue (TTM)314.09M
Gross Profit (TTM)244.36M
EBITDA-4.14M
Profit Margin-5.46%
Operating Margin-1.72%
Return on Equity-2.95%
Return on Assets-2.04%
Shares Outstanding39.18M
Shares Float17.27M
Beta0.49
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%